Ralph Passarella

Ralph Passarella is the CEO and Co-Founder of OneStudyTeam, a company focused on optimizing clinical trials and improving patient access to new therapies.12 Here's a comprehensive overview of his background and achievements:

Professional Experience

Ralph Passarella has been leading OneStudyTeam since its inception in September 2015.1 He is also the CEO and Co-Founder of Reify Health, Inc., a position he has held since January 2012.1 OneStudyTeam operates as a business entity within Reify Health, providing trial optimization software and clinical trial infrastructure.2

Prior to his current roles, Passarella was involved in other entrepreneurial ventures:

• Co-Founder and Board Member of Signal Vine (November 2013 - December 2021)
• Fellow at Rock Health (June 2012 - August 2012)

Education

Passarella has a strong academic background in medicine and biology:

• MD/PhD from The Johns Hopkins University School of Medicine (2010 - 2018)
• BA in Molecular and Cellular Biology, with High Honors, from Vanderbilt University (2006 - 2010)

Achievements and Recognition

Throughout his career, Passarella has received several honors and awards:

• Best Undergraduate Research from the American Association of Cancer Research (April 2009)
• Health 2.0 Developer Challenge Finalist (September 2011)
• Top TENN Scholar at Vanderbilt University (2006)
• Most Outstanding Undergraduate Research in Biological Sciences at Vanderbilt University (May 2010)
• Excellence in Medical Student Research at Johns Hopkins University School of Medicine (January 2011 and January 2012)

Vision and Impact

Under Passarella's leadership, OneStudyTeam aims to accelerate clinical trials and make them more accessible.3 The company's mission is to remove clinical trial operations as a bottleneck in delivering new therapies to patients.3 Passarella believes in engaging patients everywhere and improving collaboration among various stakeholders in the clinical trial ecosystem.4

Ralph Passarella's innovative approach and dedication to improving clinical research have positioned him as a notable figure in the healthcare technology industry.